Trial
NCT01844700
1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwell Health
Collaborators
—
Condition
High Risk MC4R Genotype
Intervention
Ziprasidone
Why stopped
very slow recruitment, no sufficient results
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-02-05